Alaunos Therapeutics | ZIOP - Operating Expenses


Alaunos Therapeutics reported $952K in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Alaunos Therapeutics USD 952K 60K Jun/2026
Amgen USD 5.69B 6B Sep/2026
AstraZeneca USD 11.55B 674M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Biogen USD 2.32B 663.6M Sep/2026
Bioline Rx USD 3.87M 386K Jun/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Celltrion KRW 133.99B 14.77B Jun/2026
Corcept Therapeutics USD 225.75M 10.9M Sep/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Curis USD 11.52M 2.5M Mar/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Gilead Sciences USD 13.04B 9.09B Sep/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Incyte USD 5.64B 4.67B Sep/2026
Intrexon USD 61.56M 26.1M Jun/2024
Ionis Pharmaceuticals USD 373M 2.76M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Karyopharm Therapeutics USD 61.83M 9.9M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Merck USD 10.75B 5.02B Sep/2026
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Novartis USD 9.88B 325M Sep/2026
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pfizer USD 89B 3.81B Sep/2026
Pharma Mar EUR 46.77M 4.24M Sep/2026
PTC Therapeutics USD 211.54M 15.12M Jun/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Regeneron Pharmaceuticals USD 33.5B 1.79B Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sartorius EUR 746.5M 1.3M Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
TG Therapeutics USD 218.66M 48.54M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025
Verastem USD 63.57M 4.56M Mar/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026